(Q35102931)

English

Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

acute myocardial infarction

1 reference

based on heuristic

inferred from title

Stefanie Dimmeler

19

object named as

Stefanie Dimmeler

0 references

David M Leistner

object named as

David M Leistner

2

0 references

1

object named as

Birgit Assmus

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

20

object named as

Andreas M Zeiher

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christian W Hamm

17

object named as

Christian W Hamm

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Volker Schächinger

3

object named as

Volker Schächinger

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4

object named as

Sandra Erbs

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Werner Haberbosch

6

object named as

Werner Haberbosch

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Rainer Hambrecht

7

object named as

Rainer Hambrecht

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

10

object named as

Roberto Corti

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

18

object named as

Torsten Tonn

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

16

object named as

Thorsten Dill

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

14

object named as

Iris Burck

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

8

object named as

Daniel Sedding

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Albrecht Elsässer

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jiangtao Yu

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Detlef G Mathey

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christine Barth

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Charlotte Mayer-Wehrstein

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Tim Sueselbeck

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

REPAIR-AMI Study Group

21

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

25 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1275-1283

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Importance of the SDF-1:CXCR4 axis in myocardial repair

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU062

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHU062

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35102931&oldid=1858557199"